CIA
MBII

Capital Impact Advisors’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Capital Impact Advisors’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-15,079
Closed -$40 – 222
2014
Q3 		$40 Hold
15,079
– – ﹤0.01% 219
2014
Q2 		$175K Buy
+15,079
New +$171K 0.13% 118

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return

Capital Impact Advisors's MBII Position: Q4 2014 in Review

Capital Impact Advisors sold out of Marrone Bio Innovations, Inc. (MBII) in Q4 2014, closing a stake of 15,079 shares — an estimated $40 sold.

Capital Impact Advisors first reported a position in MBII in Q2 2014 and held it in 2 quarters. The position peaked at $175K in Q2 2014. 37 funds tracked by Wall St. Rank hold MBII as of Q4 2014.

  • Capital Impact Advisors reported no remaining Marrone Bio Innovations, Inc. position as of Q4 2014 after selling out during the quarter.
  • Capital Impact Advisors sold 15,079 Marrone Bio Innovations, Inc. shares in Q4 2014, an estimated $40.
  • Capital Impact Advisors first reported a position in Marrone Bio Innovations, Inc. in Q2 2014 and held it in 2 quarters.
  • Capital Impact Advisors's Marrone Bio Innovations, Inc. position peaked at $175K in Q2 2014.
  • 37 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q4 2014.

Based on Capital Impact Advisors's 13F filing for Q4 2014, filed 25 Feb 2015.